GP Oral Tren- Metribolone also known as Methyltrienolone from Geneza Pharmaceuticals is considered to be the most potent AAS produced. It is actually an orally active form of Trenbolone chemically altered into a 17-alkylated compound. Obviously, this means serious liver toxicity .Most simply put, Methyltrienolone is the oral version of trenbolone acetate. If you know how potent and toxic trenbolone is in the injectable form, you can probably imagine how strong it is when taken orally! In fact, even at microgram dosages, it is 15-20 times more toxic than GP Oxy. That is toxic! The drug is fairly resistant to DHT conversion but does bind easily to scalp and prostate androgen receptor sites.
Methyltrienolone does not aromatize and does not possess estrogenic activity, but it can cause progestogenic side effects, which can promote the development of gynecomastia, inhibit the production of endogenous testosterone, and increase fatty interlayers. Methyltrienolone is the most powerful androgen, and the occurrence of androgenic side effects should be expected, including skin fatness, acne, and facial and body hair growth. This drug is categorically contraindicated for women. Since methyltrienolone is a 17-alpha methylated drug, it is hepatotoxic for the liver. The drug is not recommended to be used for more than 4 weeks orally and 6-8 weeks in the injectable form. The intake of methyltrinolone in injectable form is several times more effective and also several times safer for the liver. This is because it passes the first pass through the liver, in contrast to the oral form. There is also a suppression of the production of endogenous testosterone. Without any intervention in stimulating the development of his testosterone, he will return to the natural level 1-4 months after the course.
Methyltrienolone is not produced as a prescription steroid product in any part of the world. With the rapid expansion of underground steroid manufacturers, this agent has been released as a black market designer compound. Those contemplating the use of underground forms of methyltrienolone should consider that such agents are being released for human use without any government approval or consideration to its safety.